Form 4 for EVH Evolent Health, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001628908-24-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-05 | 2024-03-01+ | EVH | Weinberg Jonathan | GC | F - Tax | $34.41 | -12.3K | 171.9K | -7% | -$422.9K |
| 2024-03-05 | 2024-03-01 | EVH | Weinberg Jonathan | GC | A - Grant | $0.00 | +21.8K | 179.3K | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-03-02 | F | D | 4,830 | $34.41 | 167,027 | D | — | — | (F4) This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 2 | Common | Class A Common Stock | 2024-03-01 | F | D | 7,460 | $34.41 | 171,857 | D | — | — | (F4) This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 3 | Common | Class A Common Stock | 2024-03-01 | A | A | 21,822 | $0.00 | 179,317 | D | — | — | (F1) Represents restricted stock units granted to Mr. Weinberg pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. (F2) Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |